Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Luteolin.
Luteolin is a flavone that modulates neuroinflammation and cellular senescence by inhibiting the NF-κB and MAPK signaling pathways while activating Nrf2-mediated antioxidant defenses.
5280445
286.24 g/mol
1.4
2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Luteolin across standard consumer modalities.
Low bulk density and poor flowability of pure luteolin powder require specific excipients like microcrystalline cellulose to ensure uniform die filling.
The intense yellow pigment of luteolin can cause significant staining of manufacturing equipment and may require high concentrations of masking agents to offset its inherent bitterness.
The high dosage required for therapeutic efficacy often exceeds the 20-30mg payload capacity of standard polymer matrices in thin-film technology.
Ready to launch a product featuring Luteolin? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Luteolin extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Luteolin payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation